Last update 24 Sep 2026

DTC-0220

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
DTC0220
Target
ROS1 x TrkA x TrkB x TrkC
Action
inhibitors, antagonists
Mechanism
ROS1 inhibitors(Proto-oncogene tyrosine-protein kinase ROS inhibitors), TrkA antagonists(Nerve growth factor receptor Trk-A antagonists), TrkB inhibitors(Neurotrophic tyrosine kinase receptor type 2 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesDigestive System Disorders+ [3]
Active Indication
Bladder CancerColorectal CancerPhiladelphia positive acute lymphocytic leukaemia+ [2]
Inactive Indication-
Originator Organization
DELiver Therapeutics, Inc.DELiver Therapeutics, Inc.
Active Organization
DELiver Therapeutics, Inc.DELiver Therapeutics, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with DTC-0220
Login to view more data
100 Translational Medicine associated with DTC-0220
Login to view more data
100 Patents (Medical) associated with DTC-0220
Login to view more data
100 Deals associated with DTC-0220
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bladder CancerPreclinical
United States
DELiver Therapeutics, Inc.DELiver Therapeutics, Inc.
22 Sep 2024
Colorectal CancerPreclinical
United States
DELiver Therapeutics, Inc.DELiver Therapeutics, Inc.
22 Sep 2024
Philadelphia positive acute lymphocytic leukaemiaPreclinical
United States
DELiver Therapeutics, Inc.DELiver Therapeutics, Inc.
22 Sep 2024
Precursor T-Cell Lymphoblastic Leukemia-LymphomaPreclinical
United States
DELiver Therapeutics, Inc.DELiver Therapeutics, Inc.
22 Sep 2024
Prostatic CancerPreclinical
United States
DELiver Therapeutics, Inc.DELiver Therapeutics, Inc.
22 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free